GlassScriptPhysician profile
Kimberly Bova
NPI 1841605078
$8,164.75
in general payments reported to CMS, 2019-2025
68 companies · $1,900 in 2025
The $1,900 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,303 · 2022: $1,358 · 2023: $1,828 · 2024: $1,776 · 2025: $1,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,504.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,073.14 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $746.80 | 2021-2025 | |
| Pfizer INC. | $467.87 | 2021-2025 | |
| Lilly USA, LLC | $417.19 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $337.51 | 2021-2025 | Trelegy Ellipta, Shingrix, Fluarix Quadrivalent |
| Sanofi-Aventis U.S. LLC | $287.73 | 2021-2024 | |
| Novo Nordisk INC | $281.25 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Xeris Pharmaceuticals, INC. | $245.00 | 2023-2025 | Keveyis, Gvoke Hypopen, Recorlev |
| Amgen INC. | $239.74 | 2021-2025 | Otezla, Repatha, Tepezza |
| Abbott Laboratories | $221.40 | 2021-2023 | Freestyle Libre |
| Otsuka America Pharmaceutical, INC. | $216.25 | 2021-2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $200.96 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.43 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Esperion Therapeutics, INC. | $200.42 | 2021-2025 | Nexletol |
| Dexcom, INC. | $191.09 | 2021-2025 | Dexcom G6 Transmitter |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $185.11 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $180.59 | 2021-2024 | |
| Medtronic, INC. | $162.95 | 2022-2025 | Minimed 780g, Intellis Adaptivestim |
| Eisai INC. | $162.43 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $141.60 | 2023-2024 | Gemtesa |
| Acadia Pharmaceuticals INC | $141.05 | 2021-2025 | Nuplazid |
| Lundbeck LLC | $136.00 | 2022-2025 | Rexulti, Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $127.31 | 2021-2023 | Trintellix |
| Sunovion Pharmaceuticals INC. | $125.50 | 2021-2022 | |
| Exact Sciences Corporation | $119.92 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Phathom Pharmaceuticals, INC. | $99.05 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.46 | 2022-2025 | Xifaxan |
| Antares Pharma, INC. | $66.20 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Axsome Therapeutics, INC. | $65.18 | 2023-2025 | Auvelity, Symbravo |
| Corium, LLC | $64.96 | 2023 | Azstarys |
| Merck Sharp & Dohme LLC | $62.59 | 2021-2023 | Dificid |
| Mylan Specialty L.P. | $53.46 | 2023-2024 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.81 | 2025 | Caplyta |
| Gilead Sciences, INC. | $44.29 | 2023 | |
| Seqirus USA INC | $43.21 | 2025 | Flucelvax, Fluad |
| Paratek Pharmaceuticals, INC. | $41.72 | 2023-2024 | Nuzyra |
| Inspire Medical Systems, INC. | $34.97 | 2024 | Inspire |
| Axonics, INC. | $31.62 | 2022 | |
| Edwards Lifesciences Corporation | $31.43 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Vbi Vaccine (Delaware) INC. | $29.17 | 2022 | |
| Boston Scientific Corporation | $27.20 | 2023 | Spectra Wavewriter |
| Abiomed | $26.92 | 2025 | |
| Intercept Pharmaceuticals, INC. | $26.90 | 2025 | |
| Intuity Medical INC | $25.54 | 2022 | |
| Ironwood Pharmaceuticals, INC | $23.99 | 2021 | |
| Urovant Sciences INC | $23.98 | 2022 | |
| Viatris Specialty LLC | $23.76 | 2025 | Yupelri |
| Philips North America LLC | $23.08 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Regeneron Healthcare Solutions, INC. | $22.21 | 2023 | Praluent, Evkeeza |
| Horizon Therapeutics Plc | $21.92 | 2023 | Krystexxa |
| Nestle Healthcare Nutrition INC. | $21.72 | 2023 | |
| Vanda Pharmaceuticals INC. | $20.81 | 2025 | Hetlioz, Fanapt |
| Sanofi Pasteur INC. | $20.58 | 2023 | |
| Corcept Therapeutics | $20.19 | 2024 | Korlym |
| Shield Therapeutics INC | $19.61 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $19.36 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $19.33 | 2024 | Eliquis |
| Teva Pharmaceuticals USA, INC. | $18.88 | 2022 | |
| Neurocrine Biosciences, INC. | $18.11 | 2022 | |
| Astellas Pharma US INC | $17.01 | 2021 | |
| Renalytix Ai, INC. | $15.83 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Almatica Pharma LLC | $15.43 | 2021 | |
| Tolmar, INC. | $15.11 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.10 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.14 | 2024 | Qelbree |
| Kowa Pharmaceuticals America, INC. | $13.79 | 2024 | Zoryve |
| Dynavax Technologies Corporation | $13.22 | 2023 | Heplisav-B |
| Genentech USA, INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
Farxiga $304Mounjaro $290Vraylar $286Prevnar 20 $227Comirnaty $227Airsupra $223Abrysvo $205Breztri $195Eliquis $191Jardiance $172Nurtec Odt $170Keveyis $169Dexcom G6 Transmitter $167Trelegy Ellipta $164Ozempic $163Rybelsus $163Rexulti $154Leqembi $150Gemtesa $142Toujeo $135Minimed 780g $123Nexletol $120Nuplazid $106Cologuard Collection Kit $104Kerendia $99.27Voquezna $99.05Qulipta $88.83Repatha $79.93Otezla $79.93Yupelri $77.22Ubrelvy $71.12Xifaxan $67.67Freestyle Libre $67.32Azstarys $64.96Linzess $64.50Zepbound $60.62Tzield $54.57Xyosted $50.45Krystexxa $47.91Caplyta $47.81Flucelvax $43.21Paxlovid $42.79Tepezza $42.06Synjardy $42.02Gvoke Hypopen $41.85Fasenra $41.80Nuzyra $41.72Auvelity $39.57Creon $38.87Wegovy $35.23Inspire $34.97Recorlev $34.48Leqvio $32.97Trintellix $27.42Vyepti $27.30Spectra Wavewriter $27.20Ocaliva $26.90Symbravo $25.61Soliqua 100/33 $24.89Fluad $24.25Ambulatory Monitoring & Diagnostics Undivided $23.08Premarin $22.50Estring $22.50Duavee $22.50Evkeeza $22.21Praluent $22.21Zenpep $21.72Hetlioz $20.81Fanapt $20.81Fluzone Quadrivalent Northern Hemisphere $20.58Flublok Quadrivalent Northern Hemisphere $20.58Fluzone High-Dose $20.58Korlym $20.19Trulicity $20.15Accrufer $19.61Tradjenta $19.21Entresto $19.20Trumenba $18.85Zavzpret $18.21Edwards Sapien 3 Ultra Transcatheter Heart Valve $17.27Dificid $16.97Intellis Adaptivestim $16.47The Cologuard Plus Collection Kit $16.08Kidneyintelx Blood Collection Convenience Kit $15.83Jatenzo $15.11Arexvy $15.05Fluarix Quadrivalent $15.05Shingrix $15.05Nocdurna $14.52Tlando $14.52Edwards Sapien 3 Transcatheter Heart Valve (Thv) $14.16Qelbree $14.14Zoryve $13.79Heplisav-B $13.22Viberzi $1.51
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Bova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.